Andrew Conroy
Impact in
- Toxicology top 10%
-
- Cancer-related Molecular Pathways
Papers in
- Oncology 7
- CAR-T cell therapy research 5
- Cancer Immunotherapy and Biomarkers 2
-
- Cancer therapeutics and mechanisms 3
- Melanoma and MAPK Pathways 1
- Co-authors
- Rachael E. Hawtin (5 shared papers)Judith A. Fox (4 shared papers)David E. Stockett (2 shared papers)Michelle R. Arkin (2 shared papers)Ute Hoch (1 shared paper)Duncan Walker (1 shared paper)Nguyêñ Duy Tân (1 shared paper)Jo Ann W. Byl (1 shared paper)
- Journals
- Cancer Research (4 papers)Molecular Cancer Therapeutics (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)Journal of Clinical Oncology (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)
- Partner nations
- United StatesItaly
In The Last Decade
Andrew Conroy
12 papers receiving 263 citations
Peers
Comparison fields: 5 of 55
- Toxicology 19
- Oncology 116
- Hematology 39
- Molecular Biology 155
- Organic Chemistry 55
Countries citing papers authored by Andrew Conroy
This map shows the geographic impact of Andrew Conroy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Conroy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Conroy more than expected).
Fields of papers citing papers by Andrew Conroy
This network shows the impact of papers produced by Andrew Conroy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Conroy. The network helps show where Andrew Conroy may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew Conroy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 132 | |
| 2 | 2009 | 110 | |
| 3 | 2014 | 6 | |
| 4 | Learning to Classify Utterances in a Task-Oriented Dialogue | 2003 | 4 |
| 5 | 2009 | 4 | |
| 6 | 2007 | 3 | |
| 7 | 2019 | 2 | |
| 8 | 2022 | 2 | |
| 9 | 2019 | 1 | |
| 10 | 2009 | 1 | |
| 11 | 2020 | 1 | |
| 12 | 2013 | 1 |
About Andrew Conroy
Andrew Conroy is a scholar working on Oncology, Molecular Biology, Pharmacology, Industrial and Manufacturing Engineering and Epidemiology, having authored 12 papers that have together received 267 indexed citations. Recurring topics across this work include CAR-T cell therapy research (5 papers), Cancer therapeutics and mechanisms (3 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cancer Genomics and Diagnostics (1 paper), Immunotherapy and Immune Responses (1 paper), Melanoma and MAPK Pathways (1 paper) and Recycled Aggregate Concrete Performance (1 paper). The work is most often cited by research in Toxicology (19 citations), Oncology (116 citations), Hematology (39 citations), Molecular Biology (155 citations) and Organic Chemistry (55 citations). Andrew Conroy has collaborated with scholars based in United States and Italy. Frequent co-authors include Rachael E. Hawtin, Judith A. Fox, David E. Stockett, Michelle R. Arkin, Ute Hoch, Duncan Walker, Nguyêñ Duy Tân, Jo Ann W. Byl, Wenjin Yang and Robert S. McDowell. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Journal for ImmunoTherapy of Cancer, Journal of Clinical Oncology and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.